|
[Related PubMed/MEDLINE] Total Number of Papers: 6
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Inhibition of DAGLbeta as a therapeutic target for pain in sickle cell disease. |
2-AG, DAGLbeta, HbAS, SCD |
2 |
2022 |
Mapping the Binding Sites of UDP and Prostaglandin E2 Glyceryl Ester in the Nucleotide Receptor P2Y6. |
PG-Gs |
3 |
2020 |
Inactivation of CES1 Blocks Prostaglandin D2 Glyceryl Ester Catabolism in Monocytes/Macrophages and Enhances Its Anti-inflammatory Effects, Whereas the Pro-inflammatory Effects of Prostaglandin E2 Glyceryl Ester Are Attenuated. |
CES1, CPO, PG-Gs, PGD2-G |
4 |
2013 |
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. |
2-AG, COX-2, HD, MAGL |
5 |
2008 |
A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism. |
2-AG, COX-2 |
6 |
2008 |
Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. |
2-AG, COX-2, MAG |
|